SALVARX GROUP PLC

salvarx-group-plc-logo

SalvaRx Group plc, formerly 3Legs Resources plc, is an investing company. The Company is engaged in drug discovery and development, focused on immune-oncology. The Company's segment is appraisal of investment targets meeting the Company's investment policy. The Company is focused on evaluation and assessment of investment opportunities in line with the investment policy. Its product is IMM60. It expects the study to evaluate approximately three treatment groups: a control arm using the standard of care (an anti-programmed death (PD)-1 therapy), a trial arm using iOX Therapeutics Ltd's drug (IMM60), and a third arm that will test the combination of IMM60 and an anti-PD1 therapy. 3Legs Management Services US LLC is the subsidiary of the Company.

#People #Financial #Website #More

SALVARX GROUP PLC

Industry:
Biotechnology Medical Device

Founded:
2007-01-01

Address:
Ramsey, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.3legsresources.com

Total Employee:
11+

Status:
Active

Contact:
+44 162 481 1611

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Font Awesome Apache Mobile Non Scaleable Content Fox Contact


Current Employees Featured

ian-b-walters_image

Ian B. Walters
Ian B. Walters CEO & Director @ SalvaRx Group PLC
CEO & Director

Stock Details


Company's stock symbol is LSE:SALV

Investments List

Date Company Article Money raised
2016-06-28 Intensity Therapeutics SalvaRx Group PLC investment in Series A - Intensity Therapeutics 10 M USD

Official Site Inspections

http://www.3legsresources.com

  • Host name: lb-182-253.above.com
  • IP address: 103.224.182.253
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...

More informations about "SalvaRx Group PLC" on Search Engine